open access
Unusual echocardiographic evidence of hypercoagulation in usual left atrial appendage as the first and only sign of COVID-19
, 1
Affiliations- Department of Cardiology and Electrotherapy, Medical University of Gdansk, Poland
open access
Abstract
Coronavirus disease 2019 (COVID-19) is a condition caused by a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease’s course ranges from entirely asymptomatic to severely ill patients. Hypercoagulation is often a complication of this disease, worsening the prognosis, which is extremely important in patients at higher risk of thromboembolic events, such as atrial fibrillation (AF), where thrombus formation in the left atrial appendage (LAA) is frequent. LAA could be of various sizes, volumes, and shapes, distinguish several morphologies, from which the WindSock LAA is the most frequent. In contrast, thromboembolic complications occur most frequently in patients with AF and the Cactus LAA. We present a clinical case of a 70-year-old woman with an initial negative real-time polymerase chain reaction (RT-PCR) test for SARS-CoV-2, suspicion of device-related infection after dual pacemaker implantation, AF, and LAA without thrombus in the initial transoesophageal echocardiography (TEE). Despite apixaban treatment, spontaneous restoration of sinus rhythm, and WindSock LAA morphology, the sludge in LAA was diagnosed in control TEE. The patient did not present any typical clinical COVID-19 symptoms but re-checked the RT-PCR test for SARS-CoV-2 infection was positive. The described case presents echocardiographic evidence of hypercoagulation as the first and only feature of SARS-CoV-2 condition besides the usual morphological presentation of the WindSock LAA.
Abstract
Coronavirus disease 2019 (COVID-19) is a condition caused by a novel virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease’s course ranges from entirely asymptomatic to severely ill patients. Hypercoagulation is often a complication of this disease, worsening the prognosis, which is extremely important in patients at higher risk of thromboembolic events, such as atrial fibrillation (AF), where thrombus formation in the left atrial appendage (LAA) is frequent. LAA could be of various sizes, volumes, and shapes, distinguish several morphologies, from which the WindSock LAA is the most frequent. In contrast, thromboembolic complications occur most frequently in patients with AF and the Cactus LAA. We present a clinical case of a 70-year-old woman with an initial negative real-time polymerase chain reaction (RT-PCR) test for SARS-CoV-2, suspicion of device-related infection after dual pacemaker implantation, AF, and LAA without thrombus in the initial transoesophageal echocardiography (TEE). Despite apixaban treatment, spontaneous restoration of sinus rhythm, and WindSock LAA morphology, the sludge in LAA was diagnosed in control TEE. The patient did not present any typical clinical COVID-19 symptoms but re-checked the RT-PCR test for SARS-CoV-2 infection was positive. The described case presents echocardiographic evidence of hypercoagulation as the first and only feature of SARS-CoV-2 condition besides the usual morphological presentation of the WindSock LAA.
Keywords
COVID-19, SARS-CoV-2, coronavirus, atrial fibrillation, left atrial appendage
About this articleTitle
Unusual echocardiographic evidence of hypercoagulation in usual left atrial appendage as the first and only sign of COVID-19
Journal
Issue
Article type
Case report
Pages
714-717
Published online
2021-05-25
Page views
6838
Article views/downloads
827
DOI
Pubmed
Bibliographic record
Folia Morphol 2021;80(3):714-717.
Keywords
COVID-19
SARS-CoV-2
coronavirus
atrial fibrillation
left atrial appendage
Authors
M. Świątczak
R. Nowak
A. Faran
E. Wabich
G. Raczak
M. Klimkiewicz
L. Daniłowicz-Szymanowicz
References (12)- Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999; 82(5): 547–554.
- Carfì A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; 324(6): 603.
- Connors J, Levy J. Thromboinflammation and the hypercoagulability of COVID‐19. J Thromb Haemost. 2020; 18(7): 1559–1561.
- Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012; 60(6): 531–538.
- Kamiński R, Kosiński A, Brala M, et al. Variability of the left atrial appendage in human hearts. PLoS One. 2015; 10(11): e0141901.
- Marietta M, Vandelli P, Mighali P, et al. COVID-19 HD Study Group. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol. Trials. 2020; 21(1): 574.
- Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020; 18(7): 1738–1742.
- Panyawongkhanti M, Fuktongphan P, Chentanez V. Morphometric study of the left atrial appendage related to closure device deployment: a cadaveric study in Thai population. Folia Morphol. 2020; 79(1): 79–85.
- Rozwadowska K, Raczak G, Sikorska K, et al. Influence of hereditary haemochromatosis on left ventricular wall thickness: does iron overload exacerbate cardiac hypertrophy? Folia Morphol. 2019; 78(4): 746–753.
- Sławiński G, Lewicka E. What should a cardiologist know about coronavirus disease 2019? Kardiol Pol. 2020; 78(4): 278–283.
- Veinot JP, Harrity PJ, Gentile F, et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation. 1997; 96(9): 3112–3115.
- Wang Y, Di Biase L, Horton RP, et al. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol. 2010; 21(9): 973–982.
